Does endoscopic intervention prevent subsequent gastrointestinal bleeding in patients with left ventricular assist devices? A retrospective study.
Endoscopic intervention, Inpatient care
Gastrointestinal bleeding
Hospital readmissions
Left ventricular-assist device
Recurrent bleeding
Journal
World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448
Informations de publication
Date de publication:
07 Jul 2021
07 Jul 2021
Historique:
received:
14
02
2021
revised:
19
04
2021
accepted:
02
06
2021
entrez:
29
7
2021
pubmed:
30
7
2021
medline:
31
7
2021
Statut:
ppublish
Résumé
Patients with left ventricular assist devices (LVADs) are at increased risk for recurrent gastrointestinal bleeding (GIB) and repeat endoscopic procedures. We assessed the frequency of endoscopy for GIB in patients with LVADs and the impact of endoscopic intervention on preventing a subsequent GIB. To evaluate for an association between endoscopic intervention and subsequent GIB. Secondary aims were to assess the frequency of GIB in our cohort, describe GIB presentations and sources identified, and determine risk factors for recurrent GIB. We conducted a retrospective cohort study of all patients at a large academic institution who underwent LVAD implantation from January 2011 - December 2018 and assessed all hospital encounters for GIB through December 2019. We performed a descriptive analysis of the GIB burden and the outcome of endoscopic procedures performed. We performed multivariate logistic regression to evaluate the association between endoscopic intervention and subsequent GIB. In the cohort of 295 patients, 97 (32.9%) had at least one GIB hospital encounter. There were 238 hospital encounters, with 55.4% (132/238) within the first year of LVAD implantation. GIB resolved on its own by discharge in 69.8% (164/235) encounters. Recurrent GIB occurred in 55.5% (54/97) of patients, accounting for 59.2% (141/238) of all encounters. Of the 85.7% (204/238) of encounters that included at least one endoscopic evaluation, an endoscopic intervention was performed in 34.8% (71/204). The adjusted odds ratio for subsequent GIB if an endoscopic intervention was performed during a GIB encounter was not significant (odds ratio 1.18, Patients implanted with LVADs whom experience recurrent GIB frequently undergo repeat admissions and endoscopic procedures. In this retrospective cohort study, adherence to endoscopic guidelines for performing endoscopic interventions did not significantly decrease the odds of subsequent GIB, thus suggesting the uniqueness of the LVAD population. A prospective study is needed to identify patients with LVAD at risk of recurrent GIB and determine more effective management strategies.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with left ventricular assist devices (LVADs) are at increased risk for recurrent gastrointestinal bleeding (GIB) and repeat endoscopic procedures. We assessed the frequency of endoscopy for GIB in patients with LVADs and the impact of endoscopic intervention on preventing a subsequent GIB.
AIM
OBJECTIVE
To evaluate for an association between endoscopic intervention and subsequent GIB. Secondary aims were to assess the frequency of GIB in our cohort, describe GIB presentations and sources identified, and determine risk factors for recurrent GIB.
METHODS
METHODS
We conducted a retrospective cohort study of all patients at a large academic institution who underwent LVAD implantation from January 2011 - December 2018 and assessed all hospital encounters for GIB through December 2019. We performed a descriptive analysis of the GIB burden and the outcome of endoscopic procedures performed. We performed multivariate logistic regression to evaluate the association between endoscopic intervention and subsequent GIB.
RESULTS
RESULTS
In the cohort of 295 patients, 97 (32.9%) had at least one GIB hospital encounter. There were 238 hospital encounters, with 55.4% (132/238) within the first year of LVAD implantation. GIB resolved on its own by discharge in 69.8% (164/235) encounters. Recurrent GIB occurred in 55.5% (54/97) of patients, accounting for 59.2% (141/238) of all encounters. Of the 85.7% (204/238) of encounters that included at least one endoscopic evaluation, an endoscopic intervention was performed in 34.8% (71/204). The adjusted odds ratio for subsequent GIB if an endoscopic intervention was performed during a GIB encounter was not significant (odds ratio 1.18,
CONCLUSION
CONCLUSIONS
Patients implanted with LVADs whom experience recurrent GIB frequently undergo repeat admissions and endoscopic procedures. In this retrospective cohort study, adherence to endoscopic guidelines for performing endoscopic interventions did not significantly decrease the odds of subsequent GIB, thus suggesting the uniqueness of the LVAD population. A prospective study is needed to identify patients with LVAD at risk of recurrent GIB and determine more effective management strategies.
Identifiants
pubmed: 34321851
doi: 10.3748/wjg.v27.i25.3877
pmc: PMC8291026
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3877-3887Informations de copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: Birati EY is recipient of research grants through the University from Impulse Dynamics and Medtronic. No relevant conflicts of interest to this manuscript; Fisher L site principle investigator for a Medtronic trial regarding video capsule endoscopy, but not related to LVADs. No relevant conflicts of interest to this manuscript; No disclosures or COI for the other authors.
Références
J Am Coll Cardiol. 2019 Apr 16;73(14):1769-1778
pubmed: 30975293
Gastrointest Endosc. 2012 May;75(5):973-9
pubmed: 22341716
J Card Fail. 2020 Apr;26(4):324-332
pubmed: 31794863
Tex Heart Inst J. 2011;38(5):552-4
pubmed: 22163133
Endosc Int Open. 2020 Mar;8(3):E301-E309
pubmed: 32140555
Gastrointest Endosc. 2019 Jan;89(1):33-43.e4
pubmed: 29935143
World J Gastroenterol. 2017 Jun 14;23(22):3945-3953
pubmed: 28652649
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Dig Dis Sci. 2016 Jun;61(6):1440-7
pubmed: 27017225
Gastroenterology Res. 2018 Apr;11(2):100-105
pubmed: 29707076
J Heart Lung Transplant. 2018 Jun;37(6):723-732
pubmed: 29402604
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Dig Dis Sci. 2016 Jun;61(6):1603-10
pubmed: 26809869
Clin Gastroenterol Hepatol. 2019 Feb;17(3):448-454
pubmed: 29906524
J Thromb Thrombolysis. 2015 Apr;39(3):337-44
pubmed: 25549823
Circ Heart Fail. 2018 Nov;11(11):e005267
pubmed: 30571195
World J Cardiol. 2015 Nov 26;7(11):792-800
pubmed: 26635927